Your browser doesn't support javascript.
loading
Fulvestrant-Palbociclib vs Letrozole-Palbociclib as Initial Therapy for Endocrine-Sensitive, Hormone Receptor-Positive, ERBB2-Negative Advanced Breast Cancer: A Randomized Clinical Trial.
Llombart-Cussac, Antonio; Pérez-García, José Manuel; Bellet, Meritxell; Dalenc, Florence; Gil-Gil, Miguel; Ruíz-Borrego, Manuel; Gavilá, Joaquín; Sampayo-Cordero, Miguel; Aguirre, Elena; Schmid, Peter; Marmé, Frederik; Di Cosimo, Serena; Gligorov, Joseph; Schneeweiss, Andreas; Albanell, Joan; Zamora, Pilar; Wheatley, Duncan; Martínez-de Dueñas, Eduardo; Amillano, Kepa; Malfettone, Andrea; Cortés, Javier.
Afiliación
  • Llombart-Cussac A; Hospital Arnau de Vilanova, Universidad Católica, Valencia, Spain.
  • Pérez-García JM; Medica Scientia Innovation Research, Barcelona, Spain.
  • Bellet M; Medica Scientia Innovation Research, Ridgewood, New Jersey.
  • Dalenc F; Medica Scientia Innovation Research, Barcelona, Spain.
  • Gil-Gil M; Medica Scientia Innovation Research, Ridgewood, New Jersey.
  • Ruíz-Borrego M; International Breast Cancer Center Quiron Group, Barcelona.
  • Gavilá J; Vall d'Hebrón Institute of Oncology, Medical Oncology Department, Vall d'Hebrón University Hospital, Barcelona, Spain.
  • Sampayo-Cordero M; Medical Oncology Department, Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse-Oncopole, Centre de recherches en cancérologie, Inserm, Toulouse, France.
  • Aguirre E; Medical Oncology Department, Institut Català d'Oncología, Insitut d'Investigació Biomèdica Bellvitge, Barcelona, Spain.
  • Schmid P; Hospital Universitario Virgen del Rocío, Sevilla, Spain.
  • Marmé F; Medical Oncology Department, Fundación Instituto Valenciano de Oncología, Valencia, Spain.
  • Di Cosimo S; Medica Scientia Innovation Research, Barcelona, Spain.
  • Gligorov J; Medica Scientia Innovation Research, Ridgewood, New Jersey.
  • Schneeweiss A; Medica Scientia Innovation Research, Barcelona, Spain.
  • Albanell J; Medica Scientia Innovation Research, Ridgewood, New Jersey.
  • Zamora P; Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, and Barts Hospital, NHS Trust, London, United Kingdom.
  • Wheatley D; University Hospital Heidelberg, Medical Faculty Mannheim Heidelberg University, Heidelberg, Germany.
  • Martínez-de Dueñas E; Medica Scientia Innovation Research, Barcelona, Spain.
  • Amillano K; Medica Scientia Innovation Research, Ridgewood, New Jersey.
  • Malfettone A; Biomarkers Unit, Department of Applied Research and Technological Development, Fondazione Istituto Di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale dei Tumori, Milano, Italy.
  • Cortés J; Institut Universitaire de Cancérologie Assistance Publique-Hôpitaux de Paris, Sorbonne Université, Paris, France.
JAMA Oncol ; 7(12): 1791-1799, 2021 12 01.
Article en En | MEDLINE | ID: mdl-34617955
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Límite: Female / Humans / Middle aged Idioma: En Revista: JAMA Oncol Año: 2021 Tipo del documento: Article País de afiliación: España
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Límite: Female / Humans / Middle aged Idioma: En Revista: JAMA Oncol Año: 2021 Tipo del documento: Article País de afiliación: España